X-41447611-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022567.3(NYX):​c.-294T>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.345 in 389,488 control chromosomes in the GnomAD database, including 16,741 homozygotes. There are 43,412 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 3731 hom., 10039 hem., cov: 23)
Exomes 𝑓: 0.37 ( 13010 hom. 33373 hem. )

Consequence

NYX
NM_022567.3 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.937
Variant links:
Genes affected
NYX (HGNC:8082): (nyctalopin) The product of this gene belongs to the small leucine-rich proteoglycan (SLRP) family of proteins. Defects in this gene are the cause of congenital stationary night blindness type 1 (CSNB1), also called X-linked congenital stationary night blindness (XLCSNB). CSNB1 is a rare inherited retinal disorder characterized by impaired scotopic vision, myopia, hyperopia, nystagmus and reduced visual acuity. The role of other SLRP proteins suggests that mutations in this gene disrupt developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant X-41447611-T-C is Benign according to our data. Variant chrX-41447611-T-C is described in ClinVar as [Benign]. Clinvar id is 368266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.569 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NYXNM_001378477.3 linkc.-57+95T>C intron_variant ENST00000378220.3 NP_001365406.2
NYXNM_022567.3 linkc.-294T>C 5_prime_UTR_premature_start_codon_gain_variant 1/2 NP_072089.2 Q9GZU5
NYXNM_022567.3 linkc.-294T>C 5_prime_UTR_variant 1/2 NP_072089.2 Q9GZU5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NYXENST00000342595 linkc.-294T>C 5_prime_UTR_premature_start_codon_gain_variant 1/21 ENSP00000340328.3 Q9GZU5
NYXENST00000342595 linkc.-294T>C 5_prime_UTR_variant 1/21 ENSP00000340328.3 Q9GZU5
NYXENST00000378220.3 linkc.-57+95T>C intron_variant 1 NM_001378477.3 ENSP00000367465.2 Q9GZU5

Frequencies

GnomAD3 genomes
AF:
0.293
AC:
32473
AN:
110680
Hom.:
3730
Cov.:
23
AF XY:
0.304
AC XY:
10011
AN XY:
32956
show subpopulations
Gnomad AFR
AF:
0.148
Gnomad AMI
AF:
0.235
Gnomad AMR
AF:
0.351
Gnomad ASJ
AF:
0.256
Gnomad EAS
AF:
0.561
Gnomad SAS
AF:
0.594
Gnomad FIN
AF:
0.408
Gnomad MID
AF:
0.213
Gnomad NFE
AF:
0.325
Gnomad OTH
AF:
0.269
GnomAD4 exome
AF:
0.366
AC:
101933
AN:
278751
Hom.:
13010
Cov.:
0
AF XY:
0.396
AC XY:
33373
AN XY:
84361
show subpopulations
Gnomad4 AFR exome
AF:
0.142
Gnomad4 AMR exome
AF:
0.384
Gnomad4 ASJ exome
AF:
0.251
Gnomad4 EAS exome
AF:
0.544
Gnomad4 SAS exome
AF:
0.587
Gnomad4 FIN exome
AF:
0.428
Gnomad4 NFE exome
AF:
0.326
Gnomad4 OTH exome
AF:
0.336
GnomAD4 genome
AF:
0.293
AC:
32496
AN:
110737
Hom.:
3731
Cov.:
23
AF XY:
0.304
AC XY:
10039
AN XY:
33021
show subpopulations
Gnomad4 AFR
AF:
0.148
Gnomad4 AMR
AF:
0.351
Gnomad4 ASJ
AF:
0.256
Gnomad4 EAS
AF:
0.561
Gnomad4 SAS
AF:
0.593
Gnomad4 FIN
AF:
0.408
Gnomad4 NFE
AF:
0.325
Gnomad4 OTH
AF:
0.271
Alfa
AF:
0.300
Hom.:
12408
Bravo
AF:
0.281

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 12, 2018- -
Congenital stationary night blindness 1A Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
11
DANN
Benign
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3013122; hg19: chrX-41306864; API